首頁 > 市場調查報告書 > 材料

市場調查報告書

商品編碼

1733449

全球棕櫚醯乙醇醯胺市場規模（按類型、應用、區域範圍和預測）

Global Palmitoylethanolamide Market Size By Type, By Application, By Geographic Scope And Forecast

出版日期: 2025年05月13日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

棕櫚醯乙醇醯胺市場規模及預測

預計 2024 年棕櫚醯乙醇醯胺 (PEA) 市場規模將達到 1,342 億美元，到 2032 年將達到 2,574 億美元，2026 年至 2032 年的複合年成長率為 6.14%。

千禧世代中，科技主導的個人成長平台的日益普及也有望對預測期內的市場成長產生正面影響。棕櫚醯乙醇醯胺市場報告對市場進行了全面評估。它對關鍵細分市場、趨勢、市場促進因素、限制因素、競爭格局以及在市場中發揮重要作用的因素進行了全面的分析。

全球棕櫚醯乙醇醯胺市場定義

棕櫚醯乙醇醯胺是一種內源性脂肪酸醯胺，屬於核因子促效劑類。人們已在體外和體內系統中透過外源性添加或施用化合物對 PEA 進行了研究。棕櫚醯乙醇醯胺，也稱為棕櫚醯乙醇胺或N-2羥乙基棕櫚醯胺，是一種天然存在的生物活性脂質，屬於N-醯基乙醇胺（NAE）家族，作用於大麻素受體（CR2）並與神經系統的發炎細胞相互作用。慢性疼痛和神經病變疼痛是臨床需求尚未被滿足的疾病。 PEA 已在各種慢性和神經病變疼痛的動物模型上進行了測試。

PEA 在急性和持續性疼痛模型中的鎮痛和鎮痛作用似乎至少部分可以透過從頭神經類固醇合成來解釋。在慢性肉芽腫性疼痛和發炎模型中，PEA 可以防止神經發生和發芽以及機械性異常疼痛，並且 PEA 可以抑制背根神經節激活，這是神經病變疼痛的壓迫標誌。 PEA 作為鎮痛和抗發炎分子的作用機制可能基於不同的方面。

全球棕櫚醯乙醇醯胺市場概況

預計預測期內市場將大幅成長。推動市場成長的關鍵因素是神經病變疼痛、纖維肌痛、多發性硬化症 (MS) 和腕隧道症候群的發病率不斷上升、疾病意識計劃的加強（尤其是在新興國家）以及治療神經病變疼痛、多發性硬化症和腕管症候群的有效組合藥物的開發。

此外，政府舉措的增加和健康意識的增強也是預計擴大全球市場的因素。對個人化藥物和更好的診斷設施的需求不斷成長可能會推動全球棕櫚醯乙醇醯胺市場的發展。

預計在預測期內，製藥商推出的新產品（例如非處方藥）將顯著成長。此外，消費者健康意識的增強和透過網路獲得的醫療知識的提高也推動了非處方藥的銷售。

然而，嚴格的法規和因該化學物質對人體健康有害而引起的健康擔憂是預計阻礙棕櫚醯乙醇醯胺市場成長的主要因素。

The rising popularity of technology-driven platforms for self-growth amongst millennials is also expected to positively impact market growth during the forecast period. The Global Palmitoylethanolamide Market report provides a holistic evaluation of the market. The report offers comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Palmitoylethanolamide Market Definition

Palmitoylethanolamide (PEA) is an endogenous fatty acid amide, belonging to the class of nuclear factor agonists PEA has been studied in in vitro and in vivo systems using exogenously added or dosed compound; there is evidence that it binds to a nuclear receptor, through which it exerts a variety of biological effects, some related to chronic inflammation and pain. Palmitoylethanolamide (PEA), also called palmitoylethanolamine or N-2 hydroxyethyl palmitamide), belongs to the family of N-acylethanolamines (NAEs), naturally occurring, biologically active lipids that act on cannabinoid receptor (CR2) and interact with inflammatory cells in the nervous system. Chronic pain and neuropathic pain are indications for which there is high unmet need in the clinic. PEA has been tested in a variety of animal models for chronic and neuropathic pain.

The analgesic and antihyperalgesic effects of PEA in two models of acute and persistent pain seemed to be explained at least partly via the de novo neurosteroid synthesis. In chronic granulomatous pain and inflammation model, PEA could prevent nerve formation and sprouting, mechanical allodynia, and PEA inhibited dorsal root ganglia activation, which is a hallmark for winding up in neuropathic pain. The mechanism of action of PEA as an analgesic and anti-inflammatory molecule is probably based on different aspects.

Global Palmitoylethanolamide Market Overview

The market is expected to see a considerable amount of growth during the forecast period. The major factors that drive the growth of the market include increase in the incidence of neuropathic pain, fibromyalgia, multiple sclerosis (MS), carpal tunnel syndrome, rise in the number of disease awareness programs especially in the developing countries, and development of effective combination drug to treat neuropathic pain, multiple sclerosis and carpal tunnel syndrome.

Moreover, increase in government initiatives and rise in health awareness are the factors expected to augment the global market. Increase in demand for personalized medicines, and better diagnostic facilities are likely to propel the global palmitoylethanolamide market.

The new product launches by pharmaceutical manufacturers such as over-the-counter drugs are expected to witness substantial growth during the forecast period. Furthermore, the growing health awareness among consumers and rising medical knowledge with the help of the internet are driving the sales of over-the-counter drugs.

However, strict rules and health concerns arising from the harmful effects of chemicals on human well-being are the major factors that are expected to hamper palmitoylethanolamide market growth.

Global Palmitoylethanolamide Market Segmentation Analysis

The Global Palmitoylethanolamide Market is segmented based on Type, Application and Geography.

Palmitoylethanolamide Market, By Type

Purity>99%
Purity>98%

Palmitoylethanolamide Market, By Application

Biology
Pharmaceutical

Palmitoylethanolamide Market, By Geography

North America
Europe
Asia Pacific
Rest of the world
North America is taking up the largest share in the Palmitoylethanolamide market and it is estimated that the region will continue dominating the market until next couple of years. Asia Pacific and Europe are also displaying a robust growth due to emergence of huge market growth opportunities in these regions.
Key Players In Palmitoylethanolamide Market

The "Global Palmitoylethanolamide Market" study report will provide a valuable insight with an emphasis on the global market. The major players in the market are Gihi Chemicals, Cayman Chemical, Synhwa Pharmachem, PeaCURE, TCI Chemicals, STA, and Wuxi Cima Science.

The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

1 INTRODUCTION OF GLOBAL PALMITOYLETHANOLAMIDE MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL PALMITOYLETHANOLAMIDE MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL PALMITOYLETHANOLAMIDE MARKET, BY TYPE

5.1 Overview
5.2 Purity>99%
5.3 Purity>98%

6 GLOBAL PALMITOYLETHANOLAMIDE MARKET, BY APPLICATION

6.1 Overview
6.2 Biology
6.3 Pharmaceutical

7 GLOBAL PALMITOYLETHANOLAMIDE MARKET, BY GEOGRAPHY

7.1 Overview
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
- 7.2.3 Mexico
7.3 Europe
- 7.3.1 Germany
- 7.3.2 U.K.
- 7.3.3 France
- 7.3.4 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Rest of Asia Pacific
7.5 Rest of the World
- 7.5.1 Latin America
- 7.5.2 Middle East

8 GLOBAL PALMITOYLETHANOLAMIDE MARKET COMPETITIVE LANDSCAPE

8.1 Overview
8.2 Company Market Ranking
8.3 Key Development Strategies

9 COMPANY PROFILES

9.1 Gihi Chemicals
- 9.1.1 Overview
- 9.1.2 Financial Performance
- 9.1.3 Product Outlook
- 9.1.4 Key Developments
9.2 Cayman Chemical
- 9.2.1 Overview
- 9.2.2 Financial Performance
- 9.2.3 Product Outlook
- 9.2.4 Key Developments
9.3 Synhwa Pharmachem
- 9.3.1 Overview
- 9.3.2 Financial Performance
- 9.3.3 Product Outlook
- 9.3.4 Key Developments
9.4 PeaCURE
- 9.4.1 Overview
- 9.4.2 Financial Performance
- 9.4.3 Product Outlook
- 9.4.4 Key Developments
9.5 TCI Chemicals
- 9.5.1 Overview
- 9.5.2 Financial Performance
- 9.5.3 Product Outlook
- 9.5.4 Key Developments
9.6 STA
- 9.6.1 Overview
- 9.6.2 Financial Performance
- 9.6.3 Product Outlook
- 9.6.4 Key Developments
9.7 Wuxi Cima Science
- 9.7.1 Overview
- 9.7.2 Financial Performance
- 9.7.3 Product Outlook
- 9.7.4 Key Developments